It looks like you're using an Ad Blocker.

Please white-list or disable AboveTopSecret.com in your ad-blocking tool.

Thank you.

 

Some features of ATS will be disabled while you continue to use an ad-blocker.

 

Help ATS via PayPal:
learn more

Clinton Foundation AIDS Program Distributed ‘Watered-Down’ Drugs To Third World Countries

page: 3
41
<< 1  2    4 >>

log in

join
share:

posted on Sep, 22 2016 @ 09:47 AM
link   
a reply to: tadaman

Then you must be for holding gun manufacturers responsible for the harm their products do. .




posted on Sep, 22 2016 @ 09:54 AM
link   

originally posted by: Sillyolme
a reply to: tadaman

Then you must be for holding gun manufacturers responsible for the harm their products do. .


Their products dont kill people. The people using those items kill people.

The drug manufacturer that watered down the drugs have killed people because of their inferior and illegally altered product.
edit on 22-9-2016 by Xcathdra because: (no reason given)



posted on Sep, 22 2016 @ 09:59 AM
link   
a reply to: YenSid

Who is the HRC supporting Hillary. Lol.

HRC is Hillary's initials it's not an organization. Ha ha ha



posted on Sep, 22 2016 @ 10:06 AM
link   

originally posted by: intrepid

originally posted by: Gothmog
a reply to: Sillyolme



So what happened? The drug company agreed to the price then supplied inferior drugs

Hillary probably asked for cheaper. Then agreed to the cheaper "watered down" version . Then used the savings to help fund her campaign.


When people use the words "probably", "if" or "but" they really have no leg to stand on. As for funding her campaign, this was resolved 3 years ago.


Come on..they are still waving whitewater around. Obviously there are no statute of limitations on the Clinton's and their sins. What's three years when we can go back decades ? ? ?



posted on Sep, 22 2016 @ 10:15 AM
link   
a reply to: Xcathdra

The only sources for this "story" are alt right blog posts and alternative news sources.
Where are the federal investigations into this? The story is years old. Why the cluck hasn't there been any legal action?

No answer....
Because the story is crap.



posted on Sep, 22 2016 @ 10:16 AM
link   
a reply to: Xcathdra

Confirmed fact huh? Confirmed by who???



posted on Sep, 22 2016 @ 11:08 AM
link   
a reply to: Sillyolme

So you cant refute the facts and instead resort to the Clinton tactic of blaming the alt right. Tell you what.. When your able to think on your won and answer instead of deflecting and using Clinton excuse talking points try answering the question.

provide sources refuting what you think is incorrect in the article.

It should be easy enough for you to do.. After all you think your more intelligent than the deplorables and alt right.

Now prove it.



posted on Sep, 22 2016 @ 11:12 AM
link   

originally posted by: Sillyolme
a reply to: Xcathdra

Confirmed fact huh? Confirmed by who???


I see you have been commenting without reading the article, where the info you are ignoring is located.



posted on Sep, 22 2016 @ 11:28 AM
link   
Clinton Health Access Initiative (CHAI)


From 2002 to 2010, as an initiative of the Clinton Foundation, 4 million patients were able to access CHAI-negotiated ARV drugs and as of today, CHAI’s work, as a separate 501(c)(3), has over 11.5 million patients accessing treatment. ]Clinton Health Access Initiative (CHAI)


Ranbaxy Laboratories

During 2004–2005, Dinesh Thakur and Rajinder Kumar, two Indian employees of Ranbaxy, blew the whistle on Ranbaxy's fabrication of drug test reports. Thakur's office computer was soon found tampered with. Ranbaxy then accused Thakur of visiting pornographic websites using his office computer, forcing him to resign in 2005. Thakur left India for the USA and contacted the Food and Drug Administration which started investigating his claims.[17] As a result, on 16 September 2008, the Food and Drug Administration issued two warning letters to Ranbaxy Laboratories Ltd. and an Import Alert for generic drugs produced by two manufacturing plants in India.[18]

By 25 February 2009 the US Food and Drug Administration said it halted reviews of all drug applications including data developed at Ranbaxy's Paonta Sahib plant in India because of a practice of falsified data and test results in approved and pending drug applications.[19]

On 8 February 2012, three batches of the proton-pump inhibitor Pantoprazole were recalled in the Netherlands due to the presence of impurities.[20]

On 9 November 2012, Ranbaxy halted production and recalled forty-one lots of atorvastatin due to glass particles being found in some bottles.[21][22] Also in 2012, an apparent dosage mistake was reported in which 20 mg tablets were found in a bottle of atorvastatin labeled as containing 10 mg tablets; this led in 2014 to the voluntary recall in the United States of some 64,000 bottles.[23]

In May 2013 the US fined the company US$500 million after it was found guilty of misrepresenting clinical generic drug data and selling adulterated drugs to the United States.[24]

In September 2013, further problems were reported, including apparent human hair in a tablet, oil spots on other tablets, toilet facilities without running water, and a failure to instruct employees to wash their hands after using the toilet.[25][26] Ranbaxy is prohibited from manufacturing FDA-regulated drugs at the Mohali facility until the company complies with US drug manufacturing requirements.[27]


*- FDA Takes New Regulatory Action Against Ranbaxy's Paonta Sahib Plant in India
Agency halts review of drug applications from plant due to evidence of falsified data; invokes Application Integrity Policy

* - Regulatory Action Against Ranbaxy
* - DOJ - Generic Drug Manufacturer Ranbaxy Pleads Guilty and Agrees to Pay $500 Million to Resolve False Claims Allegations, cGMP Violations and False Statements to the FDA

* - Report: Clinton Foundation distributed ‘watered-down’ AIDS drugs to third world countries

CHAI announced in October 2003 it was going to distribute generic, low-cost HIV drugs from four foreign drug manufacturers: Ranbaxy; Cipla of Mumbai, India; Matrix Labs of Hydrabad, India; Aspen Pharmacare of Johannesburg, South Africa.

CHAI’s endorsement also allowed Ranbaxy to manufacture HIV drugs that would be bought by the U.S. government under the President’s Emergency Plan for AIDS relief — a $15 billion initiative proposed by former President George W. Bush.

The flow of U.S. funds combined with Clinton’s endorsement allowed the four foreign drug manufactures to become “good acquisition targets,” according to the report.

The companies enjoyed great financial profits and they “exploded as they partnered with the Foundation for several years,” the report states.

Blackburn says the worst part of the story were the “false hopes” offered by the Clinton Foundation.

“You think about the emotional state of health care workers as they are dealing with these individuals and the emotional state of the patients. To me it’s disturbing and very sad,” she said.


your turn...
edit on 22-9-2016 by Xcathdra because: (no reason given)



posted on Sep, 22 2016 @ 11:34 AM
link   
So when did the Clinton Foundation stop procuring products from Ranbaxy?

Looks like 2010, shortly after the FDA noted issues with their products?

Aside from the standard attacks on anything with the name Clinton attached .... what's the alleged issue here?



posted on Sep, 22 2016 @ 11:41 AM
link   
a reply to: Gryphon66

The issues started in 2004-2005 when the whistle blowers came forward.. The CHAI started using them in 2003.

Also see my post above yours for the detailed info.
edit on 22-9-2016 by Xcathdra because: (no reason given)



posted on Sep, 22 2016 @ 11:55 AM
link   
a reply to: Xcathdra

Yes, thank you ... but the Clinton Foundation (actually CHAI) stopped procuring the drugs and dispensing them in 2010, soon after the US FDA became involved?

The "whistle-blowers" took the information to the FDA which launched an investigation, right in 2008?

That's based on your material above.

You're unclear EXACTLY when CHAI stopped dispensing the questionable products though ... did you have more on that?



posted on Sep, 22 2016 @ 12:15 PM
link   
Actually, I'm mistaken ... apparently CAHI stopped dealing with Ranbaxy in 2008:



After the FDA's 2008 import alert, CHAI stopped sourcing drugs from Ranbaxy with the exception of two small batch medications, of which Ranbaxy was the sole supplier.


Economic Times - Times of India


edit on 22-9-2016 by Gryphon66 because: Corrected link title



posted on Sep, 22 2016 @ 02:48 PM
link   
a reply to: Sillyolme

Human Rights Campaign

www.hrc.org...



posted on Sep, 22 2016 @ 03:18 PM
link   
a reply to: Gryphon66

The first warning letter went out in 2002. The second went out in 2006. The Whistle blowers notified the FDA / DOJ in 2006.

CHAI used the company from 2003 to the present as I have not seen anything showing they cut contact with the Indian company.


ETA - what are the small batch medications and what are they used for?


edit on 22-9-2016 by Xcathdra because: (no reason given)



posted on Sep, 22 2016 @ 03:35 PM
link   
a reply to: Gryphon66

Here's Billy boy in 2013 heaping praise upon them. He had to have known by this time that the FDA was not pleased with Ranbaxy.


By ET Bureau | Apr 11, 2013, 11.15 AM IST

MUMBAI: Former US president Bill Clinton praised Indian generic drug companies such as Ranbaxy and Cipla for their stellar contribution in the fight against the HIV/AIDS scourge, saying their cheap drugs saved millions of lives.


Bill Clinton praises pharma companies Ranbaxy and Cipla for fight against AIDS



posted on Sep, 22 2016 @ 06:09 PM
link   

originally posted by: Xcathdra
a reply to: Gryphon66

The first warning letter went out in 2002. The second went out in 2006. The Whistle blowers notified the FDA / DOJ in 2006.

CHAI used the company from 2003 to the present as I have not seen anything showing they cut contact with the Indian company.


ETA - what are the small batch medications and what are they used for?



Here's everything the FDA has on actions against Ranbaxy: FDA Enforcement Activities - Ranbaxy

Yes, the earliest "action" letter is 2002. That is a notification regarding an inspection that did not meet FDA criteria at one Ranbaxy manufacturing center. That has nothing to do with the topic here.

The letters in 2006 are about inconsistencies in an inspection of Ranbaxy facilities in India. The letters in 2008 are following up on those.

I provided a clear reference above that stated that CAHI had stopped using Ranbaxy HIV/AIDS drugs in 2008.

I'm working on a follow up to that citation for a more complete answer to your question..

I encourage others to look at the actual actions taken by the FDA vis a vis Ranbaxy. I believe you will find that the facts are considerably different than are being presented via the wingnut echo chamber (WND, etc.).



posted on Sep, 22 2016 @ 06:16 PM
link   
One thing deserves noting however. The settlement (largest ever against a generic drug manfufacturer) touted earlier doesn't have anything to do per se with "HIV drugs.".

Copy of the Department of Justice Settlement US vs. Ranbaxy USA, Inc.



Ranbaxy USA admitted to introducing into interstate commerce certain batches of adulterated drugs that were produced at Paonta Sahib in 2005 and 2006, including Sotret, gabapentin, and ciprofloxacin. Sotret is Ranbaxy’s branded generic form of isotretinoin, a drug used to treat severe recalcitrant nodular acne; gabapentin is a drug used to treat epilepsy and nerve pain; ciprofloxacin is a broad-spectrum antibiotic.


Also, this action regards drugs introduced into the US marketplace only.

edit on 22-9-2016 by Gryphon66 because: Noted



posted on Sep, 22 2016 @ 06:21 PM
link   
Further, here's an important note from the FDA's "Question and Answers" Announcement regarding Ranbaxy:




For consumers currently taking a Ranbaxy product affected by this action, FDA strongly advises these consumers not to interrupt their drug therapy, which could have serious implications for their health.

To date, FDA has no evidence of harm to any patients who have taken drugs made in these two facilities. Today’s actions are being taken as a preventive measure because the manufacturing processes at these two Ranbaxy facilities do not meet FDA’s regulatory standards. By focusing on the process used to make these drugs, FDA is working to prevent the possibility that a product that does not meet its specifications could get into the hands of U.S. consumers.

Additionally, consumers should know that products from Ranbaxy’s other plants are not affected by this action. FDA has inspected those facilities and to date they have met FDA standards for drug manufacturing.


Emphasis, mine.

Questions and Answers on Drugs Manufactured at the Dewas and Paonta Sahib Facilities of Ranbaxy Laboratories, Ltd.
edit on 22-9-2016 by Gryphon66 because: Spelling



posted on Sep, 22 2016 @ 06:44 PM
link   
Of course, a lot of OP's references to tabloid articles are referring to a report dropped by Trump surrogate Representative Marcia Blackburn (R) of Tennessee.

Her favorite pastimes are interminable "investigations" of anything Clinton, global climate change denial, etc.

Here's a link to the REPORT that so excited the wingnut press (and perhaps prompted OP's thread.)

Blackburn's Report

In it you'll find a short summary of all recent Clinton Foundation conspiracy theories that have been mostly ignored by everyone but right-wing media.

The sections on Ranbaxy start on pg. 17-19.

You may note that Rep. Blackburn's "report" conflates actions taken in the US against Ranbaxy USA (linked earlier) with issues related to the anti-viral drugs that are the "focus" of concern here.

The criminal case THAT WAS SETTLED as noted above is U.S. v. Ranbaxy USA, Inc., JFM-13-CR-0238 (D. Md.).]US v. Ranbaxy USA, etc. Link

edit on 22-9-2016 by Gryphon66 because: Noted


While the settled criminal case does address issues with anti-viral drugs, the Settlement doesn't note any further statement regarding those drugs and is very specific (see above) as to which drugs were involved.

Read these documents for yourself if interested. It is quite clear that, as usual, the Blackburn report is just on the edge of willing misrepresentation ... at least from what I've read.

Your mileage may vary.
edit on 22-9-2016 by Gryphon66 because: Noted



new topics

top topics



 
41
<< 1  2    4 >>

log in

join